BD · 2 months ago
Tech 2, Quality Control
DOM Santo Cristobal - Nave 25-Merengue
Full-time
Onsite
New Grad, Entry LevelBD is a company focused on critical care technologies. They are seeking a Tech 2 in Quality Control to perform CAD drafting duties and provide engineering support for the Process Development Center.
Health CareMedical DeviceTechnical Support
Responsibilities
Perform basic redline reviews, Update basic CAD drawings per Engineering Change Requests (ECR) through PDM (Product Data Management) system for PDC in collaboration with team members
Convert/Modify basic sketches or marked-up prints into engineering drawings utilizing CAD software (e.g. AutoCAD, Solidworks, Creo) in accordance with process and procedures for PDC
Provide routine R&D engineering support from Design, Fabrication/Rapid Prototyping, Engineering Studies to Equipment Troubleshooting on projects within PDC under supervision of other team members and/or stakeholders
Qualification
Required
Ability to read, comprehend, write, and speak English
Experience in reading, interpreting, and creating of CAD drawings and electrical schematic
Proficient in Solidworks is a must
Proficient in drafting principles, techniques and procedures
Preferred
Experience with Rapid Prototyping will be advantageous
Able to operate drill press, grinders, engine lathe, or other machines to modify parts tested or to fabricate experimental parts for testing will be advantageous
Experience on Creo, AutoCAD, CAD PDM preferred
Company
BD helps advance clinical therapy with the process for patients and health care providers with innovative technology services and solutions.
Founded in 1897
10001+ employees
H1B Sponsorship
BD has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2023 (66)
2022 (4)
2021 (3)
Funding
Current Stage
Public CompanyTotal Funding
$540MKey Investors
Steris
2023-08-02Post Ipo Equity· $540M
1962-04-23IPO
Leadership Team
Tom Polen
Chairman, CEO and President
Richard Byrd
Executive Vice President and President of the BD Interventional Segment
Recent News
EIN Presswire
2026-01-09
Company data provided by crunchbase